Abstract:
A binding assay device can provide an array of parallel channels with reservoirs for accommodating varying volumes of liquid samples for assay. The device generally can comprise a substantially planar base and a substantially planar top plate with open channels formed in its bottom surface. One embodiment includes a removable cassette, which forms the open channels when placed between the base and top plates. Reservoirs can be formed at the ends of the open channels with closed channels extending from the reservoirs to the top surface of the top plate. Open channels or elongated grooves or sockets can be formed in the top surface of the top plate to accommodate plug-in manifolds that can be in fluid communication with the closed channels. By allowing varying volumes of liquid samples t~ be placed in the reservoirs, the device can provide improved and/or optimized binding assay reactivities and/or band intensities.
Abstract:
The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (l-3)-β-D-glucan in a sample.
Abstract:
The present invention features, inter alia , compositions and methods useful for identifying one or more types of microorganisms, if and when present, in a sample or plurality of samples ( e.g ., in one or more samples tested in parallel). More specifically, the present compositions and methods can be used in, e.g., determining whether a subject has a microbial infection ( e.g ., a bacterial, fungal, protozoal, or viral infection), determining the identity of the microbe(s) causing the infection, and/or determining, or helping to determine, an appropriate anti-microbial treatment regimen for a subject identified as having an infection ( e.g. , an appropriate antibiotic, anti-fungal, anti-viral, or other treatment regimen).
Abstract:
The invention is directed to methods of using novel Babesia antigen peptides in detecting Babesia spp. in a sample. The methods may be adapted to assays suitable for high blood volume screening, use for clinical diagnosis of patients with babesiosis, or assaying blood contaminated with Babesia spp. , such as B. microti .
Abstract:
The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-β-D-glucan in a sample.
Abstract:
The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-β-D-glucan in a sample.